2-Methoxyethylamine → HCID 178496027, compound
Reaction equation
[CH3:1][O:2][CH2:3][CH2:4][NH2:5].[F:6][CH:7]([F:39])[C:8]1[N:12]([C:13]2[N:18]=[C:17]([N:19]3[CH2:24][CH2:23][O:22][CH2:21][CH2:20]3)[N:16]=[C:15]([O:25][C@H:26]3[CH2:31][CH2:30][C@H:29]([C:32]([OH:34])=O)[CH2:28][CH2:27]3)[CH:14]=2)[C:11]2[CH:35]=[CH:36][CH:37]=[CH:38][C:10]=2[N:9]=1.C(N(CC)C(C)C)(C)C.F[P-](F)(F)(F)(F)F.[H+].CN(C(=[N+](C)C)ON1C2=NC=CC=C2N=N1)C>CN(C)C=O.C(Cl)(Cl)Cl.O>[F:39][CH:7]([F:6])[C:8]1[N:12]([C:13]2[N:18]=[C:17]([N:19]3[CH2:24][CH2:23][O:22][CH2:21][CH2:20]3)[N:16]=[C:15]([O:25][C@H:26]3[CH2:31][CH2:30][C@H:29]([C:32]([NH:5][CH2:4][CH2:3][O:2][CH3:1])=[O:34])[CH2:28][CH2:27]3)[CH:14]=2)[C:11]2[CH:35]=[CH:36][CH:37]=[CH:38][C:10]=2[N:9]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
To a 2-methoxyethanamine (1.9 mg) were added a solution of trans-4-({6-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-2-(morpholin-4-yl)pyrimidin-4-yl}oxy)cyclohexanecarboxylic acid (11.8 mg) and N,N-diisopropylethylamine (10.5 μL) in N,N-dimethylformamide (400 μL), and were added a solution of N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methylMethanaminium hexafluorophosphoric acid (11.4 mg) in N,N-dimethylformamide (100 μL), followed by stirring at room temperature overnight. To the reaction solution were added water and chloroform, followed by liquid separation, and the organic layer was concentrated under reduced pressure. The residue was subjected to preparative purification with HPLC to obtain trans-4-({6-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-2-(morpholin-4-yl)pyrimidin-4-yl}oxy)-N-(2-methoxyethyl)cyclohexanecarboxamide (5.9 mg).
Workup
- customfollowed by liquid separation
- concentrationthe organic layer was concentrated under reduced pressure
- customThe residue was subjected to preparative purification with HPLC
Sources & evidence
- ORD record
- ord-b8a989c11bcf4c7ebb11c69ec2a2d366
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08912180B2
Reaction notes
Loading…